Chordate Medical Holding AB (OSTO:CMH) Price-to-Operating-Cash-Flow : (As of May. 24, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Chordate Medical Holding AB Price-to-Operating-Cash-Flow?

As of today (2024-05-24), Chordate Medical Holding AB's share price is kr0.05. Chordate Medical Holding AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was kr-0.09. Hence, Chordate Medical Holding AB's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Chordate Medical Holding AB's Price-to-Operating-Cash-Flow or its related term are showing as below:

OSTO:CMH's Price-to-Operating-Cash-Flow is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 20.95
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Chordate Medical Holding AB's Cash Flow from Operations per share for the three months ended in Dec. 2023 was kr-0.03. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was kr-0.09.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 21.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 39.80% per year.

During the past 9 years, Chordate Medical Holding AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 62.60% per year. The lowest was -156.20% per year. And the median was 30.40% per year.

Chordate Medical Holding AB Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Chordate Medical Holding AB's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordate Medical Holding AB Price-to-Operating-Cash-Flow Chart

Chordate Medical Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Chordate Medical Holding AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Chordate Medical Holding AB's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, Chordate Medical Holding AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chordate Medical Holding AB's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Chordate Medical Holding AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Chordate Medical Holding AB's Price-to-Operating-Cash-Flow falls into.

Chordate Medical Holding AB Price-to-Operating-Cash-Flow Calculation

Chordate Medical Holding AB's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.05	/	-0.09
	=

Chordate Medical Holding AB's Share Price of today is kr0.05.
Chordate Medical Holding AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.09.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Chordate Medical Holding AB Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Chordate Medical Holding AB's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Chordate Medical Holding AB (OSTO:CMH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chordate Medical Holding AB (OSTO:CMH) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

K1Z:Germany

Address

c/o Regus, Kistagangen 20B, Kista, SWE, 164 40

Website

https://www.chordate.com

Chordate Medical Holding AB is a medical technology company that has developed and patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel and Saudi Arabia. The company's product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients who are 18 years old or older. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.

Chordate Medical Holding AB (OSTO:CMH) Headlines

No Headlines